CAG
TMO icon

Csenge Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Csenge Advisory Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
2,687
+47
+2% +$25.5K 0.06% 250
2025
Q4 		$1.53M Sell
2,640
-119
-4% -$67.3K 0.07% 227
2025
Q3 		$1.34M Sell
2,759
-464
-14% -$216K 0.06% 232
2025
Q2 		$1.3M Sell
3,223
-202
-6% -$84.5K 0.07% 224
2025
Q1 		$1.46M Sell
3,425
-47
-1% -$25.5K 0.08% 193
2024
Q4 		$1.81M Sell
3,472
-335
-9% -$184K 0.1% 162
2024
Q3 		$2.27M Buy
3,807
+67
+2% +$39.7K 0.12% 141
2024
Q2 		$2.07M Buy
3,740
+194
+5% +$111K 0.12% 132
2024
Q1 		$2.06M Buy
3,546
+158
+5% +$88.7K 0.12% 142
2023
Q4 		$1.8M Sell
3,388
-202
-6% -$97.8K 0.11% 154
2023
Q3 		$1.82M Sell
3,590
-86
-2% -$45.8K 0.12% 142
2023
Q2 		$1.92M Buy
3,676
+164
+5% +$88.5K 0.13% 127
2023
Q1 		$2.02M Sell
3,512
-369
-10% -$208K 0.15% 127
2022
Q4 		$2.14M Buy
3,881
+315
+9% +$167K 0.17% 114
2022
Q3 		$1.81M Buy
3,566
+559
+19% +$313K 0.15% 127
2022
Q2 		$1.63M Buy
3,007
+232
+8% +$128K 0.14% 146
2022
Q1 		$1.64M Buy
2,775
+429
+18% +$246K 0.13% 142
2021
Q4 		$1.2M Sell
2,346
-81
-3% -$50.6K 0.11% 164
2021
Q3 		$1.39M Buy
2,427
+81
+3% +$44.5K 0.12% 160
2021
Q2 		$1.2M Buy
2,346
+1,489
+174% +$703K 0.11% 164
2021
Q1 		$410K Sell
857
-134
-14% -$64K 0.04% 325
2020
Q4 		$462K Sell
991
-227
-19% -$106K 0.06% 240
2020
Q3 		$543K Sell
1,218
-2
-0.2% -$826 0.07% 208
2020
Q2 		$442K Buy
1,220
+221
+22% +$74.1K 0.06% 216
2020
Q1 		$283K Buy
+999
New +$315K 0.07% 222
2018
Q4 		– Sell
-81
Closed -$19K – 1366
2018
Q3 		$19K Sell
81
-1,482
-95% -$341K 0.01% 401
2018
Q2 		$332K Buy
1,563
+105
+7% +$22.3K 0.12% 167
2018
Q1 		$301K Buy
+1,458
New +$306K 0.1% 194
2017
Q4 		– Sell
-1,064
Closed -$201K – 284
2017
Q3 		$201K Buy
+1,064
New +$193K 0.08% 241

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Csenge Advisory Group's TMO Position: Q1 2026 in Review

Csenge Advisory Group increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q1 2026, buying an estimated $25.5K and bringing the position to 2,687 shares worth $1.32M. The position accounts for 0.06% of the portfolio, ranked #250.

Csenge Advisory Group first reported a position in TMO in Q3 2017 and has held it in 29 quarters since. The position peaked at $2.27M in Q3 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Csenge Advisory Group held 2,687 shares of Thermo Fisher Scientific worth $1.32M as of Q1 2026.
  • Csenge Advisory Group bought 47 Thermo Fisher Scientific shares in Q1 2026, an estimated $25.5K.
  • Thermo Fisher Scientific made up 0.06% of Csenge Advisory Group's portfolio in Q1 2026, its #250 holding.
  • Csenge Advisory Group first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 29 quarters since.
  • Csenge Advisory Group's Thermo Fisher Scientific position peaked at $2.27M in Q3 2024.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.